These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2764343

  • 1. Failure of aspirin to impair bovine platelet function.
    Gentry PA, Tremblay RR, Ross ML.
    Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ.
    N Engl J Med; 1981 Jan 08; 304(2):76-9. PubMed ID: 7003384
    [Abstract] [Full Text] [Related]

  • 3. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2.
    FitzGerald GA, Lupinetti M, Charman SA, Charman WN.
    J Pharmacol Exp Ther; 1991 Dec 08; 259(3):1043-9. PubMed ID: 1762060
    [Abstract] [Full Text] [Related]

  • 4. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
    Honda N, Ohnishi K, Fujishiro T, Ikeda M, Ito K.
    Am J Vet Res; 2007 Dec 08; 68(12):1399-406. PubMed ID: 18052747
    [Abstract] [Full Text] [Related]

  • 5. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
    Grauer GF, Rose BJ, Toolan L, Thrall MA, Colgan SP.
    Am J Vet Res; 1992 Sep 08; 53(9):1631-5. PubMed ID: 1416368
    [Abstract] [Full Text] [Related]

  • 6. Low-dose aspirin in pregnancy.
    Sibai BM, Mirro R, Chesney CM, Leffler C.
    Obstet Gynecol; 1989 Oct 08; 74(4):551-7. PubMed ID: 2797631
    [Abstract] [Full Text] [Related]

  • 7. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS.
    Thromb Haemost; 2008 Jul 08; 100(1):83-9. PubMed ID: 18612542
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK.
    Platelets; 2003 Jul 08; 14(7-8):421-7. PubMed ID: 14713511
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
    Wagner WR, Hubbell JA.
    J Lab Clin Med; 1992 Jun 26; 119(6):690-7. PubMed ID: 1534345
    [Abstract] [Full Text] [Related]

  • 11. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J, Mehta P, Lawson DL, Ostrowski N, Brigmon L.
    J Lab Clin Med; 1985 Sep 26; 106(3):246-52. PubMed ID: 3928780
    [Abstract] [Full Text] [Related]

  • 12. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL, Rand ML, Barrow DV, Packham MA.
    Atherosclerosis; 1991 May 26; 88(1):77-86. PubMed ID: 1878012
    [Abstract] [Full Text] [Related]

  • 13. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM, Hennekens CH, Tofler GH, Lipinska I, Buring JE.
    J Cardiovasc Risk; 1996 Apr 26; 3(2):209-12. PubMed ID: 8836865
    [Abstract] [Full Text] [Related]

  • 14. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T.
    Eur J Cardiothorac Surg; 2005 Apr 26; 27(4):606-10. PubMed ID: 15784358
    [Abstract] [Full Text] [Related]

  • 15. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC, Wang TW, Wang WY, Hsieh PW, Wu YC.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):37-43. PubMed ID: 16313903
    [Abstract] [Full Text] [Related]

  • 16. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, Davì G, Patrono C.
    J Am Coll Cardiol; 2009 Feb 24; 53(8):667-77. PubMed ID: 19232899
    [Abstract] [Full Text] [Related]

  • 17. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
    Moscardó A, Vallés J, Latorre A, Madrid I, Santos MT.
    Thromb Res; 2013 Apr 24; 131(4):e154-9. PubMed ID: 23352311
    [Abstract] [Full Text] [Related]

  • 18. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
    Samama M, Lecrubier C, Conard J, Hotchen M, Breton-Gorius J, Vargaftig B, Chignard M, Lagarde M, Dechavanne M.
    Br J Haematol; 1981 Jun 24; 48(2):293-303. PubMed ID: 7195274
    [Abstract] [Full Text] [Related]

  • 19. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, Schrör K, Hohlfeld T.
    Circulation; 2003 Aug 05; 108(5):542-7. PubMed ID: 12874188
    [Abstract] [Full Text] [Related]

  • 20. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD, Kinlough-Rathbone RL, Mustard JF.
    J Lab Clin Med; 1986 Feb 05; 107(2):148-53. PubMed ID: 3080538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.